Sanofi and Regeneron: Severe asthma index

Pharmaceutical company Sanofi and biotechnology company Regeneron created the "Severe Asthma Index" (SAI), an independent study comparing severe asthma management across 29 OECD countries, to provoke policy change.

Summary

How do you achieve real change in health policy, with thousands of chronic illnesses competing for political attention? Our experience showed that, in this space, headline-grabbing PR achieved only limited cut-through. Instead, we needed to speak the true language of policy: data. Enter the "Severe Asthma Index"- a first-of-its-kind, independent study comparing severe asthma management across 29 OECD countries. A year in the making, with an interactive web tool allowing policymakers to explore the results in detail, it has already generated support from MEPs, interest from the European Commission, and advocacy from leading respiratory health organisations....

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands